[1] |
Nelson JD, Craig JP, Akpek EK, et al. TFOS DEWS Ⅱ Introduction[J]. Ocul Surf, 2017, 15(3): 269-275.
|
[2] |
Knop E, Knop N, Millar T, et al. The international workshop on meibomian gland dysfunction: report of the subcommittee on anatomy, physiology, and pathophysiology of the meibomian gland[J]. Invest Ophthalmol Vis Sci, 2011, 52(4): 1938-1978.
|
[3] |
Chhadva P, Goldhardt R, Galor A. Meibomian gland disease: the role of gland dysfunction in dry eye disease[J]. Ophthalmology, 2017, 124(11S): S20-S26.
|
[4] |
Villani E, Ceresara G, Beretta S, et al. In vivo confocal microscopy of meibomian glands in contact lens wearers[J]. Invest Ophthalmol Vis Sci, 2011, 52(8): 5215-5219.
|
[5] |
Matsumoto Y, Shigeno Y, Sato EA, et al. The evaluation of the treatment response in obstructive meibomian gland disease by in vivo laser confocal microscopy[J]. Graefes Arch Clin Exp Ophthalmol, 2009, 247(6): 821-829.
|
[6] |
Yamaguchi T. Inflammatory response in dry eye[J]. Invest Ophthalmol Vis Sci, 2018, 59(14): DES192-DES199.
|
[7] |
Hassanzadeh S, Varmaghani M, Zarei-Ghanavati S, et al. Global prevalence of meibomian gland dysfunction: a systematic review and meta-analysis[J]. Ocul Immunol Inflamm, 2021, 29(1): 66-75.
|
[8] |
Rhee MK, Mah FS. Inflammation in dry eye disease: how do we break the cycle?[J]. Ophthalmology, 2017, 124(S11): S14-S19.
|
[9] |
McCulley JP, Shine WE. The lipid layer of tears: dependent on meibomian gland function[J]. Exp Eye Res, 2004, 78(3): 361-365.
|
[10] |
Ambaw YA, Timbadia DP, Raida M, et al. Profile of tear lipid mediator as a biomarker of inflammation for meibomian gland dysfunction and ocular surface diseases: Standard operating procedures[J/OL].(2020-10-03).
URL
|
[11] |
Cuevas M, González-García MJ, Castellanos E, et al. Correlations among symptoms, signs, and clinical tests in evaporative-type dry eye disease caused by Meibomian gland dysfunction (MGD)[J]. Curr Eye Res, 2012, 37(10): 855-863.
|
[12] |
Benítez-del-Castillo JM, Acosta MC, Wassfi MA, et al. Relation between corneal innervation with confocal microscopy and corneal sensitivity with noncontact esthesiometry in patients with dry eye[J]. Invest Ophthalmol Vis Sci, 2007, 48(1): 173-181.
|
[13] |
Labbé A, Alalwani H, van Went C, et al. The relationship between subbasal nerve morphology and corneal sensation in ocular surface disease[J]. Invest Ophthalmol Vis Sci, 2012, 53(8): 4926-4931.
|
[14] |
Choi EY, Kang HG, Lee CH, et al. Langerhans cells prevent subbasal nerve damage and upregulate neurotrophic factors in dry eye disease[J]. PLoS One, 2017, 12(4): e0176153.
|
[15] |
Azizi S, Uçak T, Yaᶊar I, et al. Evaluation of the corneal layers in meibomian-gland-dysfunction-related dry eye by in vivo slit-scanning confocal microscopy[J]. Semin Ophthalmol, 2017, 32(3): 377-383.
|
[16] |
Fu J, Chou Y, Hao R, et al. Evaluation of ocular surface impairment in meibomian gland dysfunction of varying severity using a comprehensive grading scale[J]. Medicine (Baltimore), 2019, 98(31): e16547.
|
[17] |
de Paiva CS, Pflugfelder SC. Corneal epitheliopathy of dry eye induces hyperesthesia to mechanical air jet stimulation[J]. Am J Ophthalmol, 2004, 137(1): 109-115.
|
[18] |
Kheirkhah A, Dohlman TH, Amparo F, et al. Effects of corneal nerve density on the response to treatment in dry eye disease[J]. Ophthalmology, 2015, 122(4): 662-668.
|
[19] |
Qazi Y, Kheirkhah A, Blackie C, et al. Clinically relevant immune-cellular metrics of inflammation in meibomian gland dysfunction[J]. Invest Ophthalmol Vis Sci, 2018, 59(15): 6111-6123.
|
[20] |
Kheirkhah A, Rahimi-Darabad R, Cruzat A, et al. Corneal epithelial immune dendritic cell alterations in subtypes of dry eye disease: a pilot in vivo confocal microscopic study[J]. Invest Ophthalmol Vis Sci, 2015, 56(12): 7179-7185.
|
[21] |
Gao N, Lee P, Yu FS. Intraepithelial dendritic cells and sensory nerves are structurally associated and functional interdependent in the cornea[J]. Sci Rep, 2016, 6: 36414.
|
[22] |
Colorado LH, Markoulli M, Edwards K. The relationship between corneal dendritic cells, corneal nerve morphology and tear inflammatory mediators and neuropeptides in healthy individuals[J]. Curr Eye Res, 2019, 44(8): 840-848.
|